Moreover, Flnb editing has been shown to be altered in esophageal and liver carcinomas due to the increased activity of ADAR1 indicating that this enzyme may also target Flnb, at least under specific conditions [38,39]. Here, FLNB is linked to hepatocellular carcinoma.